Xenon Pharmaceuticals Inc. has grown revenue −7.4% a year over three years and −25% a year over five. Revenue growth, 3-year annual rate: −7.4% (Biotechnology median +21%). Revenue growth, 5-year rate: −25%, growth has picked up over the last three years. Years of annual history on file: 14, FY2012 to FY2025, as filed.

XENEXenon Pharmaceuticals Inc.

HealthcareUSD

$63.80

$33.4352 weeks$68.91

Is it growing?

Is XENE growing?

Xenon Pharmaceuticals Inc. has grown revenue −7.4% a year over three years and −25% a year over five.

−7.4%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −25%
Revenue growth, 5-year rate · −7.4% over three · growth has picked up over the last three years
Years of annual history on file: 14
Years of annual history on file · FY2012 to FY2025, as filed

Details›